Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM)

CUSIP: 00773U108

Q1 2021 13F Holders as of 31 Mar 2021

Holder snapshot 7 signals
Share change
+923,679
Put/Call ratio
364%
SEC-reported price per share
$9.86
Number of holders
131
Value change
+$7,873,874
Number of buys
51
Open additional details 1 more signal available
Number of sells
78
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
22,163,711

Security key

00773U108

Report period

Q1 2021

Institutions

131

Top holders

10

Ownership snapshot

Top reported holders of ADVM - Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
RA CAPITAL MANAGEMENT, L.P.
Disclosed value leader
RA CAPITAL MANAGEMENT, L.P.
Comparable rows
15/15
Latest evidence
31 Dec 2020
13F Lead comparable stake: 43% Showing 1-6 of 15 holder rows.

Quick read

RA CAPITAL MANAGEMENT, L.P. leads the comparable SEC ownership view at 43%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens RA CAPITAL MANAGEMENT, L.P.'s linked filing trail.
Comparable ownership Top 5
RA CAPITAL MANAGEMENT, L.P. 43%
Avoro Capital Advisors LLC 36%
RTW INVESTMENTS, LP 33%
BlackRock Finance, Inc. 32%
ORBIMED ADVISORS LLC 25%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
RA CAPITAL MANAGEMENT, L.P.
13F
Company
13F
43%
$103,006,000
9,502,383 shares
31 Dec 2020
Avoro Capital Advisors LLC
13F
Company
13F
36%
$86,720,000
8,000,000 shares
31 Dec 2020
RTW INVESTMENTS, LP
13F
Company
13F
33%
$78,345,000
7,227,364 shares
31 Dec 2020
BlackRock Finance, Inc.
13F
Company
13F
32%
$76,343,000
7,042,768 shares
31 Dec 2020
ORBIMED ADVISORS LLC
13F
Company
13F
25%
$59,632,000
5,501,144 shares
31 Dec 2020
Sonic Fund II, L.P.
13F
Company
13F
23%
$55,303,000
5,101,787 shares
31 Dec 2020
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
131
Shares
95,104,058
Rows available
131
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 holders
152
Q1 2021 holders
131
Holder diff
-21
Investor Q4 2020 Shares Q1 2021 Shares Share Diff Share Chg % Q4 2020 value Q1 2021 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .